>Marché des laxatifs au Moyen-Orient et en Afrique, par type (laxatifs osmotiques, laxatifs stimulants, laxatifs en vrac et laxatifs lubrifiants et émollients), arômes (avec arôme et sans arôme), source (naturelle, synthétique et autres), indication (constipation chronique, syndrome du côlon irritable avec constipation, constipation induite par les opioïdes, constipation aiguë et autres), mode d'achat (sur ordonnance et en vente libre), forme posologique (comprimés, gélules, poudre, liquide et gels, suppositoires et autres), voie d'administration (orale et rectale), type de population (enfants et adultes), canal de vente (hôpitaux, centres de soins pour personnes âgées, soins à domicile, pharmacies, épiceries/magasins de santé et de beauté et autres), canal de distribution (ventes directes, grossistes et autres), pays (Afrique du Sud, Arabie saoudite, Émirats arabes unis, Égypte, Koweït, Israël et reste du Moyen-Orient et de l'Afrique) Tendances et prévisions de l'industrie 2028.
Analyse et perspectives du marché : marché des laxatifs au Moyen-Orient et en Afrique
Le marché des laxatifs du Moyen-Orient et de l'Afrique devrait connaître une croissance du marché au cours de la période de prévision de 2021 à 2028. Data Bridge Market Research analyse que le marché croît avec un TCAC de 4,9% au cours de la période de prévision de 2021 à 2028 et devrait atteindre 396,24 millions USD d'ici 2028. Le niveau élevé de sécurité associé aux produits laxatifs et l'accent croissant mis sur la production de laxatifs à partir de matériaux naturels, synthétiques et biodégradables sont les principaux moteurs qui ont propulsé la demande du marché au cours de la période de prévision.
Les laxatifs sont des agents qui augmentent/stimulent le transit intestinal ou ramollissent les selles. Ils aident à accélérer le transit intestinal, ce qui accélère le mouvement du tube digestif pour stimuler le transit intestinal. Ils sont utilisés pour traiter la constipation , une affection caractérisée par des selles difficiles, peu fréquentes et parfois douloureuses. Les laxatifs sont disponibles en vente libre . Les quatre principaux types de laxatifs sont les laxatifs osmotiques, les laxatifs stimulants, les laxatifs volumineux, les lubrifiants et les laxatifs émollients.
Les laxatifs présentent des caractéristiques telles que le besoin croissant de produits sûrs et efficaces aura un impact sur le lancement de nouveaux produits par les fabricants sur le marché, ce qui augmentera sa demande, ainsi que l'augmentation des investissements dans la recherche et le développement conduisant à la croissance du marché. Actuellement, diverses études de recherche sont en cours, ce qui devrait créer un avantage concurrentiel pour les fabricants afin de développer des produits nouveaux et innovants qui devraient offrir diverses autres opportunités sur le marché des laxatifs. Cependant, la disponibilité de produits alternatifs et la moindre efficacité des laxatifs pour la constipation induite par les opioïdes sont des facteurs qui devraient freiner la croissance du marché au cours de la période de prévision.
Le rapport sur le marché des laxatifs fournit des détails sur la part de marché, les nouveaux développements et l'analyse du pipeline de produits, l'impact des acteurs du marché national et local, analyse les opportunités en termes de poches de revenus émergentes, les changements dans la réglementation du marché, les approbations de produits, les décisions stratégiques, les lancements de produits, les expansions géographiques et les innovations technologiques sur le marché. Pour comprendre l'analyse et le scénario du marché, contactez-nous pour un briefing d'analyste, notre équipe vous aidera à créer une solution d'impact sur les revenus pour atteindre votre objectif souhaité.
Portée et taille du marché des laxatifs au Moyen-Orient et en Afrique
Le marché des laxatifs du Moyen-Orient et de l'Afrique est classé en dix segments notables en fonction du type, des saveurs, de la source, de l'indication, du mode d'achat, de la forme posologique, de la voie d'administration, du type de population, du canal de vente et du canal de distribution. La croissance entre les segments vous aide à analyser les niches de croissance et les stratégies pour aborder le marché et déterminer vos principaux domaines d'application et la différence entre vos marchés cibles.
- Sur la base du type, le marché des laxatifs du Moyen-Orient et de l'Afrique est segmenté en laxatifs osmotiques, laxatifs en vrac, laxatifs stimulants et laxatifs lubrifiants et émollients. En 2021, le segment des laxatifs stimulants domine le marché car ces laxatifs ont pour fonction de nettoyer les intestins avant un examen/une intervention chirurgicale.
- Sur la base des arômes, le marché des laxatifs du Moyen-Orient et de l'Afrique est segmenté en avec et sans arôme. En 2021, le segment avec arôme domine le marché en raison de son acceptation sur le marché et de sa popularité auprès des consommateurs.
- Sur la base de la source, le marché des laxatifs du Moyen-Orient et de l'Afrique est segmenté en produits naturels, synthétiques et autres. En 2021, le segment synthétique domine le marché en raison de la disponibilité accrue des laxatifs synthétiques sous forme de médicaments en vente libre.
- Sur la base des indications, le marché des laxatifs du Moyen-Orient et de l'Afrique est segmenté en constipation chronique, syndrome du côlon irritable avec constipation, constipation induite par les opioïdes, constipation aiguë et autres. En 2021, le segment de la constipation chronique domine le marché en raison de la disponibilité facile des médicaments en vente libre contre la constipation.
- En fonction du mode d'achat, le marché des laxatifs au Moyen-Orient et en Afrique est segmenté en médicaments sur ordonnance et en vente libre. En 2021, le segment des médicaments en vente libre domine le marché en raison de coûts plus faibles et il permet de personnaliser le médicament en fonction des besoins des patients.
- Sur la base de la forme posologique, le marché des laxatifs du Moyen-Orient et de l'Afrique est segmenté en comprimés, gélules, poudres, liquides et gels, suppositoires et autres. En 2021, le segment des comprimés domine le marché car il s'agit de la méthode d'administration de médicaments la plus économique.
- On the basis of route of administration, the Middle East and Africa laxative market is segmented into oral and rectal. In 2021, oral segment is dominating the market as it is the safest, most convenient, and economical method of drug administration.
- On the basis of population type, the Middle East and Africa laxative market is segmented into children and adults. In 2021, adults segment is expected to dominate the Middle East and Africa laxative market due to changes in a regular routine, such as traveling or eating or going to bed at different times.
- On the basis of sales channel, the Middle East and Africa laxative market is segmented into hospitals, elderly care centers, home healthcare, pharmacy stores, grocery / health and beauty stores and others. In 2021, hospitals segment is expected to dominate the Middle East and Africa laxative market as the hospital is a healthcare institution with an organized medical and professional staff. It provides medical, nursing, and other health-related services to patients.
- On the basis of distribution channel, the Middle East and Africa laxative market is segmented into direct sales, whole sales and others. In 2021, direct sales segment is expected to dominate the Middle East and Africa laxative market as it results in direct contact with the seller and enables selling of products directly to the customer.
Laxative Market Country Level Analysis
The laxative market is analyzed and market size information is provided on the basis of type, flavours, source, indication, mode of purchase, dosage form, route of administration, population type, sales channel and distribution channel.
The countries covered in the laxative market report are the Saudi Arabia, South Africa, UAE, Israel, Kuwait, Egypt, and rest of Middle East & Africa.
In Middle East & Africa region, South Africa and Kuwait is expected to grow with the highest growth rate in the forecast period of 2021 to 2028 because of rising geriatric population and high beverage consumption causing constipation problems in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Middle East and Africa brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Rise in Geriatric Population is Boosting the Market Growth of Laxatives in Middle East and Africa Region
Le marché des laxatifs vous fournit également une analyse détaillée du marché pour chaque pays, la croissance de l'industrie des produits laxatifs avec les ventes de médicaments laxatifs, l'impact des progrès de la technologie laxative et les changements dans les scénarios réglementaires avec leur soutien au marché des laxatifs. Les données sont disponibles pour la période historique de 2010 à 2019.
Analyse du paysage concurrentiel et des parts de marché des laxatifs
Le paysage concurrentiel du marché des laxatifs fournit des détails par concurrent. Les détails inclus sont la présentation de l'entreprise, les finances de l'entreprise, les revenus générés, le potentiel du marché, les investissements dans la recherche et le développement, les nouvelles initiatives du marché, les sites et installations de production, les forces et les faiblesses de l'entreprise, le lancement du produit, les pipelines d'essais de produits, les approbations de produits, les brevets, la largeur et l'ampleur du produit, la domination des applications, la courbe de survie technologique. Les points de données ci-dessus fournis ne concernent que l'orientation de l'entreprise vers le marché des laxatifs.
Les principales entreprises présentes sur le marché des laxatifs au Moyen-Orient et en Afrique sont Boehringer Ingelheim International GmbH, GlaxoSmithKline plc., Bayer AG, Fresenius Kabi Austria GmbH, Procter & Gamble, Sun Pharmaceutical Industries Ltd., Sanofi Aventis US LLC (une filiale de Sanofi), Mallinckrodt, Abbott, Hikma Pharmaceuticals PLC, Dr Reddy's Laboratories Ltd, Cipla Inc., Albert David Ltd, Aspen Pharmacare Australia Pty Ltd et RECORDATI SpA, entre autres. Les analystes de DBMR comprennent les atouts de la concurrence et fournissent une analyse concurrentielle pour chaque concurrent séparément.
De nombreux lancements de produits et accords sont également initiés par des entreprises du monde entier, ce qui accélère également le marché des laxatifs.
Par exemple,
- En janvier 2018, Bayer AG avait lancé MiraLAX, un médicament populaire contre la constipation. MiraLAX avait reçu un sursis de la part de la FDA. La FDA a déclaré que le médicament serait poursuivi pendant encore 6 mois. Bayer AG avait cessé de distribuer le médicament laxatif, car il provoquait des effets secondaires tels que des problèmes de comportement. Par conséquent, cela a entraîné une perte de revenu net et une croissance négative du marché.
- En octobre 2021, Abbott a lancé le laxatif Duphalac en Inde. Duphalac Bears au goût de fraise est un laxatif et un complément alimentaire conforme aux réglementations de la FSSAI. Il offre les avantages d'un prébiotique de confiance et stimule la croissance de bonnes bactéries dans le système digestif. Le lancement du produit marquerait une étape importante dans l'amélioration de la santé des enfants. Il se traduira par une augmentation des ventes nettes et une gamme de produits plus étendue.
La collaboration, le lancement de produits, l'expansion commerciale, les récompenses et la reconnaissance, les coentreprises et d'autres stratégies des acteurs du marché améliorent le marché de l'entreprise sur le marché des laxatifs, ce qui offre également l'avantage à l'organisation d'améliorer son offre de laxatifs.
SKU-
Accédez en ligne au rapport sur le premier cloud mondial de veille économique
- Tableau de bord d'analyse de données interactif
- Tableau de bord d'analyse d'entreprise pour les opportunités à fort potentiel de croissance
- Accès d'analyste de recherche pour la personnalisation et les requêtes
- Analyse de la concurrence avec tableau de bord interactif
- Dernières actualités, mises à jour et analyse des tendances
- Exploitez la puissance de l'analyse comparative pour un suivi complet de la concurrence
Table des matières
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF MIDDLE EAST AND AFRICA LAXATIVE MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MIDDLE EAST AND AFRICA LAXATIVE MARKET: SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 TYPE LIFELINE CURVE
2.8 DBMR MARKET POSITION GRID
2.9 VENDOR SHARE ANALYSIS
2.1 MARKET INDICATION COVERAGE GRID
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PORTERS FIVE FORCES MODEL
4.2 PESTEL ANALYSIS
5 EPIDEMIOLOGY
6 MIDDLE EAST AND AFRICA LAXATIVE MARKET: REGULATIONS
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 INCREASED PREVALENCE OF CONSTIPATION
7.1.2 RISE IN CLINICAL TRIALS
7.1.3 ACCLIMATIZATION OF SEDENTARY LIFESTYLE
7.1.4 RISE IN GERIATRIC POPULATION
7.1.5 RISE IN PRODUCT APPROVALS
7.2 RESTRAINTS
7.2.1 LESS EFFICACY OF LAXATIVES FOR OPIOID-INDUCED CONSTIPATION
7.2.2 AVAILABILITY OF ALTERNATIVES
7.2.3 LAXATIVE ABUSE
7.2.4 SIDE EFFECTS RELATED TO THE USE OF LAXATIVES
7.3 OPPORTUNITIES
7.3.1 RISE OF OTC LAXATIVE MEDICATIONS
7.3.2 STRATEGIC INITIATIVES BY MARKET PLAYERS
7.3.3 INCREASED USE OF BULK-LAXATIVES
7.4 CHALLENGES
7.4.1 RISE OF PRODUCT RECALL
7.4.2 PATIENT COMPLIANCE REGARDING THE USE OF LAXATIVES
8 IMPACT OF COVID-19 ON THE MIDDLE EAST AND AFRICA LAXATIVE MARKET
8.1 IMPACT ON PRICE
8.2 IMPACT ON DEMAND
8.3 IMPACT ON SUPPLY CHAIN
8.4 STRATEGIC DECISIONS FOR MANUFACTURERS
8.5 CONCLUSION
9 MIDDLE EAST AND AFRICA LAXATIVE MARKET, BY TYPE
9.1 OVERVIEW
9.2 OSMOTIC LAXATIVES
9.2.1 OSMOTIC LAXATIVES WITHOUT ELECTROLYTES
9.2.1.1 LACTULOSE
9.2.1.2 MAGNESIUM HYDROXIDE SOLUTION
9.2.1.3 EPSOM SALTS
9.2.1.4 OTHERS
9.2.2 OSMOTIC LAXATIVES WITH ELECTROLYTES
9.2.2.1 GOLYTELY
9.2.2.2 COLYTE
9.2.2.3 OTHERS
9.3 STIMULANT LAXATIVES
9.3.1 BISACODYL
9.3.2 CASTOR OIL
9.3.3 SENNA
9.3.4 PHENOLPHTALEIN
9.3.5 OTHERS
9.4 BULK LAXATIVES
9.4.1 PSYLLIUM
9.4.2 METHYL CELLULOSE
9.4.3 POLYCARBOPHIL
9.4.4 OTHERS
9.5 LUBRICANT AND EMOLLIENT LAXATIVES
9.5.1 MINERAL OIL
9.5.2 GLYCERIN SUPPOSITORIES
9.5.3 OTHERS
10 MIDDLE EAST AND AFRICA LAXATIVE MARKET, BY FLAVORS
10.1 OVERVIEW
10.2 WITH FLAVOR
10.2.1 FRUIT FLAVOR
10.2.2 HERBAL FLAVOR
10.2.3 OTHERS
10.3 WITHOUT FLAVOR
11 MIDDLE EAST AND AFRICA LAXATIVE MARKET, BY SOURCE
11.1 OVERVIEW
11.2 SYNTHETIC
11.2.1 BISACODYL
11.2.2 PICOSULPHATE
11.2.3 PHENOLPHTHALEIN
11.2.4 OXYPHENISATIN
11.3 NATURAL
11.3.1 PSYLLIUM
11.3.2 SENNA
11.3.3 RHUBARB
11.3.4 SLIPPERY ELM
12 MIDDLE EAST AND AFRICA LAXATIVE MARKET, BY INDICATION
12.1 OVERVIEW
12.2 CHRONIC CONSTIPATION
12.3 IRRITABLE BOWEL SYNDROME WITH CONSTIPATION
12.4 OPIOID-INDUCED CONSTIPATION
12.5 ACUTE CONSTIPATION
12.6 OTHERS
13 MIDDLE EAST AND AFRICA LAXATIVE MARKET, BY MODE OF PURCHASE
13.1 OVERVIEW
13.2 OVER THE COUNTER
13.3 PRESCRIPTION
14 MIDDLE EAST AND AFRICA LAXATIVE MARKET, BY DOSAGE FORM
14.1 OVERVIEW
14.2 TABLETS
14.3 CAPSULES
14.4 POWDER
14.5 LIQUID & GELS
14.6 SUPPOSITORIES
14.7 OTHERS
15 MIDDLE EAST AND AFRICA LAXATIVE MARKET, BY ROUTE OF ADMINISTRATION
15.1 OVERVIEW
15.2 ORAL
15.3 RECTAL
16 MIDDLE EAST AND AFRICA LAXATIVE MARKET, BY POPULATION TYPE
16.1 OVERVIEW
16.2 ADULTS
16.3 CHILDREN
17 MIDDLE EAST AND AFRICA LAXATIVE MARKET, BY SALES CHANNEL
17.1 OVERVIEW
17.2 HOSPITALS
17.3 PHARMACY STORES
17.4 ELDERLY CARE CENTERS
17.5 HOME HEALTHCARE
17.6 GROCERY/HEALTH AND BEAUTY STORES
17.7 OTHERS
18 MIDDLE EAST AND AFRICA LAXATIVE MARKET, BY DISTRIBUTION CHANNEL
18.1 OVERVIEW
18.2 DIRECT SALES
18.3 WHOLE SALERS
18.4 OTHERS
19 MIDDLE EAST AND AFRICA LAXATIVE MARKET, BY REGION
19.1 MIDDLE EAST & AFRICA
19.1.1 SAUDI ARABIA
19.1.2 SOUTH AFRICA
19.1.3 U.A.E.
19.1.4 ISRAEL
19.1.5 KUWAIT
19.1.6 EGYPT
19.1.7 REST OF MIDDLE EAST & AFRICA
20 MIDDLE EAST AND AFRICA LAXATIVE MARKET: COMPANY LANDSCAPE
20.1 COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA
21 SWOT ANALYSIS
22 COMPANY PROFILE
22.1 BAYER AG
22.1.1 COMPANY SNAPSHOT
22.1.2 REVENUE ANALYSIS
22.1.3 COMPANY SHARE ANALYSIS
22.1.4 PRODUCT PORTFOLIO
22.1.5 RECENT DEVELOPMENT
22.2 PROCTER & GAMBLE
22.2.1 COMPANY SNAPSHOT
22.2.2 REVENUE ANALYSIS
22.2.3 COMPANY SHARE ANALYSIS
22.2.4 PRODUCT PORTFOLIO
22.2.5 RECENT DEVELOPMENTS
22.3 FRESENIUS KABI AUSTRIA GMBH (A SUBSIDIARY OF FRESENIUS KABI AG)
22.3.1 COMPANY SNAPSHOT
22.3.2 REVENUE ANALYSIS
22.3.3 COMPANY SHARE ANALYSIS
22.3.4 PRODUCT PORTFOLIO
22.3.5 RECENT DEVELOPMENT
22.4 SANOFI-AVENTIS U.S. LLC (A SUBSIDIARY OF SANOFI)
22.4.1 COMPANY SNAPSHOT
22.4.2 REVENUE ANALYSIS
22.4.3 COMPANY SHARE ANALYSIS
22.4.4 PRODUCT PORTFOLIO
22.4.5 RECENT DEVELOPMENTS
22.5 ABBOTT
22.5.1 COMPANY SNAPSHOT
22.5.2 REVENUE ANALYSIS
22.5.3 PRODUCT PORTFOLIO
22.5.4 RECENT DEVELOPMENT
22.6 ALBERT DAVID LTD.
22.6.1 COMPANY SNAPSHOT
22.6.2 REVENUE ANALYSIS
22.6.3 PRODUCT PORTFOLIO
22.6.4 RECENT DEVELOPMENT
22.7 ASPEN PHARMACARE AUSTRALIA PTY LTD. (A SUBSIDIARY OF ASPEN HOLDINGS)
22.7.1 COMPANY SNAPSHOT
22.7.2 REVENUE ANALYSIS
22.7.3 PRODUCT PORTFOLIO
22.7.4 RECENT DEVELOPMENT
22.8 AVRIO HEALTH L.P.
22.8.1 COMPANY SNAPSHOT
22.8.2 PRODUCT PORTFOLIO
22.8.3 RECENT DEVELOPMENT
22.9 BIOCHEMIX HEALTHCARE PVT. LTD.
22.9.1 COMPANY SNAPSHOT
22.9.2 PRODUCT PORTFOLIO
22.9.3 RECENT DEVELOPMENT
22.1 BOEHRINGER INGELHEIM INTERNATIONAL GMBH
22.10.1 COMPANY SNAPSHOT
22.10.2 REVENUE ANALYSIS
22.10.3 PRODUCT PORTFOLIO
22.10.4 RECENT DEVELOPMENT
22.11 CIPLA INC.
22.11.1 COMPANY SNAPSHOT
22.11.2 REVENUE ANALYSIS
22.11.3 PRODUCT PORTFOLIO
22.11.4 RECENT DEVELOPMENTS
22.12 DR. REDDY’S LABORATORIES LTD.
22.12.1 COMPANY SNAPSHOT
22.12.2 REVENUE ANALYSIS
22.12.3 PRODUCT PORTFOLIO
22.12.4 RECENT DEVELOPMENTS
22.13 GLAXOSMITHKLINE PLC
22.13.1 COMPANY SNAPSHOT
22.13.2 REVENUE ANALYSIS
22.13.3 PRODUCT PORTFOLIO
22.13.4 RECENT DEVELOPMENT
22.14 HERMES PHARMA
22.14.1 COMPANY SNAPSHOT
22.14.2 PRODUCT PORTFOLIO
22.14.3 RECENT DEVELOPMENTS
22.15 HIKMA PHARMACEUTICALS PLC
22.15.1 COMPANY SNAPSHOT
22.15.2 REVENUE ANALYSIS
22.15.3 PRODUCT PORTFOLIO
22.15.4 RECENT DEVELOPMENT
22.16 LNK INTERNATIONAL, INC.
22.16.1 COMPANY SNAPSHOT
22.16.2 PRODUCT PORTFOLIO
22.16.3 RECENT DEVELOPMENT
22.17 MALLINCKRODT
22.17.1 COMPANY SNAPSHOT
22.17.2 REVENUE ANALYSIS
22.17.3 PRODUCT PORTFOLIO
22.17.4 RECENT DEVELOPMENTS
22.18 PRESTIGE CONSUMER HEALTHCARE INC.
22.18.1 COMPANY SNAPSHOT
22.18.2 REVENUE ANALYSIS
22.18.3 PRODUCT PORTFOLIO
22.18.4 RECENT DEVELOPMENT
22.19 RECORDATI S.P.A.
22.19.1 COMPANY SNAPSHOT
22.19.2 REVENUE ANALYSIS
22.19.3 PRODUCT PORTFOLIO
22.19.4 RECENT DEVELOPMENT
22.2 SALIX PHARMACEUTICALS (A SUBSIDIARY OF BAUSCH HEALTH COMPANIES INC.)
22.20.1 COMPANY SNAPSHOT
22.20.2 REVENUE ANALYSIS
22.20.3 PRODUCT PORTFOLIO
22.20.4 RECENT DEVELOPMENTS
22.21 SUN PHARMACEUTICAL INDUSTRIES LTD.
22.21.1 COMPANY SNAPSHOT
22.21.2 REVENUE ANALYSIS
22.21.3 PRODUCT PORTFOLIO
22.21.4 RECENT DEVELOPMENT
22.22 TORRENT PHARMACEUTICALS LTD.
22.22.1 COMPANY SNAPSHOT
22.22.2 REVENUE ANALYSIS
22.22.3 PRODUCT PORTFOLIO
22.22.4 RECENT DEVELOPMENT
23 QUESTIONNAIRE
24 RELATED REPORTS
Liste des tableaux
TABLE 1 MIDDLE EAST AND AFRICA LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 2 MIDDLE EAST AND AFRICA LAXATIVE MARKET, BY TYPE, 2019-2028 (UNITS)
TABLE 3 MIDDLE EAST AND AFRICA OSMOTIC LAXATIVES IN LAXATIVES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 4 MIDDLE EAST AND AFRICA OSMOTIC LAXATIVES IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 5 MIDDLE EAST AND AFRICA OSMOTIC LAXATIVES WITHOUT ELECTROLYTES IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 6 MIDDLE EAST AND AFRICA OSMOTIC LAXATIVES WITH ELECTROLYTES IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 7 MIDDLE EAST AND AFRICA STIMULANT LAXATIVE IN LAXATIVE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 8 MIDDLE EAST AND AFRICA STIMULANT LAXATIVE IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 9 MIDDLE EAST AND AFRICA BULK LAXATIVES IN LAXATIVE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 10 MIDDLE EAST AND AFRICA BULK LAXATIVE IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 11 MIDDLE EAST AND AFRICA LUBRICANT AND EMOLLIENT LAXATIVES IN LAXATIVE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 12 MIDDLE EAST AND AFRICA LUBRICANT AND EMOLLIENT LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 13 MIDDLE EAST AND AFRICA LAXATIVE MARKET, BY FLAVORS, 2019-2028 (USD MILLION)
TABLE 14 MIDDLE EAST AND AFRICA WITH FLAVOR IN LAXATIVE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 15 MIDDLE EAST AND AFRICA WITH FLAVOR IN LAXATIVE MARKET, BY FLAVOR, 2019-2028 (USD MILLION)
TABLE 16 MIDDLE EAST AND AFRICA WITHOUT FLAVOR IN LAXATIVE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 17 MIDDLE EAST AND AFRICA LAXATIVE MARKET, BY SOURCE, 2019-2028 (USD MILLION)
TABLE 18 MIDDLE EAST AND AFRICA SYNTHETIC IN LAXATIVE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 19 MIDDLE EAST AND AFRICA SYNTHETIC IN LAXATIVE MARKET, BY SOURCE, 2019-2028 (USD MILLION)
TABLE 20 MIDDLE EAST AND AFRICA NATURAL IN LAXATIVE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 21 MIDDLE EAST AND AFRICA NATURAL IN LAXATIVE MARKET, BY SOURCE, 2019-2028 (USD MILLION)
TABLE 22 MIDDLE EAST AND AFRICA LAXATIVE MARKET, INDICATION, 2019-2028 (USD MILLION)
TABLE 23 MIDDLE EAST AND AFRICA CHRONIC CONSTIPATION IN LAXATIVE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 24 MIDDLE EAST AND AFRICA IRRITABLE BOWEL SYNDROME WITH CONSTIPATION IN LAXATIVE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 25 MIDDLE EAST AND AFRICA OPIOID-INDUCED CONSTIPATION IN LAXATIVE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 26 MIDDLE EAST AND AFRICA ACUTE CONSTIPATION IN LAXATIVE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 27 MIDDLE EAST AND AFRICA OTHERS IN LAXATIVE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 28 MIDDLE EAST AND AFRICA LAXATIVE MARKET, BY MODE OF PURCHASE, 2019-2028 (USD MILLION)
TABLE 29 MIDDLE EAST AND AFRICA LAXATIVE MARKET, BY MODE OF PURCHASE, 2019-2028 (UNITS)
TABLE 30 MIDDLE EAST AND AFRICA OVER THE COUNTER IN LAXATIVE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 31 MIDDLE EAST AND AFRICA PRESCRIPTION IN LAXATIVE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 32 MIDDLE EAST AND AFRICA LAXATIVE MARKET, BY DOSAGE FORM, 2019-2028 (USD MILLION)
TABLE 33 MIDDLE EAST AND AFRICA TABLETS IN LAXATIVE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 34 MIDDLE EAST AND AFRICA CAPSULES IN LAXATIVE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 35 MIDDLE EAST AND AFRICA POWDER IN LAXATIVE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 36 MIDDLE EAST AND AFRICA LIQUID & GELS IN LAXATIVE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 37 MIDDLE EAST AND AFRICA SUPPOSITORIES IN LAXATIVE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 38 MIDDLE EAST AND AFRICA OTHERS IN LAXATIVE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 39 MIDDLE EAST AND AFRICA LAXATIVE MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)
TABLE 40 MIDDLE EAST AND AFRICA ORAL IN LAXATIVE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 41 MIDDLE EAST AND AFRICA RECTAL IN LAXATIVE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 42 MIDDLE EAST AND AFRICA LAXATIVE MARKET, BY POPULATION TYPE, 2019-2028 (USD MILLION)
TABLE 43 MIDDLE EAST AND AFRICA ADULTS IN LAXATIVE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 44 MIDDLE EAST AND AFRICA CHILDREN IN LAXATIVE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 45 MIDDLE EAST AND AFRICA LAXATIVE MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 46 MIDDLE EAST AND AFRICA HOSPITALS IN LAXATIVE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 47 MIDDLE EAST AND AFRICA PHARMACY STORES IN LAXATIVE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 48 MIDDLE EAST AND AFRICA ELDERLY CARE CENTERS IN LAXATIVE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 49 MIDDLE EAST AND AFRICA HOME HEALTHCARE IN LAXATIVE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 50 MIDDLE EAST AND AFRICA GROCERY/HEALTH AND BEAUTY STORES IN LAXATIVE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 51 MIDDLE EAST AND AFRICA OTHERS IN LAXATIVE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 52 MIDDLE EAST AND AFRICA LAXATIVE MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 53 MIDDLE EAST AND AFRICA DIRECT SALES IN LAXATIVE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 54 MIDDLE EAST AND AFRICA WHOLE SALERS IN LAXATIVE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 55 MIDDLE EAST AND AFRICA OTHERS IN LAXATIVE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 56 MIDDLE EAST & AFRICA LAXATIVE MARKET, BY COUNTRY, 2019-2028 (USD MILLION)
TABLE 57 MIDDLE EAST & AFRICA LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 58 MIDDLE EAST & AFRICA LAXATIVES MARKET, BY TYPE, 2019-2028 (UNITS)
TABLE 59 MIDDLE EAST & AFRICA STIMULANT LAXATIVE IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 60 MIDDLE EAST & AFRICA OSMOTIC LAXATIVE IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 61 MIDDLE EAST & AFRICA OSMOTIC LAXATIVE WITH ELECTROLYTES IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 62 MIDDLE EAST & AFRICA OSMOTIC LAXATIVE WITHOUT ELECTROLYTES IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 63 MIDDLE EAST & AFRICA BULK LAXATIVE IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 64 MIDDLE EAST & AFRICA LUBRICANT AND EMOLLIENT LAXATIVE IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 65 MIDDLE EAST & AFRICA LAXATIVE MARKET, BY FLAVORS, 2019-2028 (USD MILLION)
TABLE 66 MIDDLE EAST & AFRICA WITH FLAVOR IN LAXATIVE MARKET, BY FLAVORS, 2019-2028 (USD MILLION)
TABLE 67 MIDDLE EAST & AFRICA LAXATIVE MARKET, BY SOURCE, 2019-2028 (USD MILLION)
TABLE 68 MIDDLE EAST & AFRICA SYNTHETIC IN LAXATIVE MARKET, BY SOURCE, 2019-2028 (USD MILLION)
TABLE 69 MIDDLE EAST & AFRICA NATURAL IN LAXATIVE MARKET, BY SOURCE, 2019-2028 (USD MILLION)
TABLE 70 MIDDLE EAST & AFRICA LAXATIVE MARKET, BY INDICATION, 2019-2028 (USD MILLION)
TABLE 71 MIDDLE EAST & AFRICA LAXATIVE MARKET, BY MODE OF PURCHASE, 2019-2028 (USD MILLION)
TABLE 72 MIDDLE EAST & AFRICA LAXATIVE MARKET, BY MODE OF PURCHASE, 2019-2028 (UNITS)
TABLE 73 MIDDLE EAST & AFRICA LAXATIVE MARKET, BY DOSAGE FORM, 2019-2028 (USD MILLION)
TABLE 74 MIDDLE EAST & AFRICA LAXATIVE MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)
TABLE 75 MIDDLE EAST & AFRICA LAXATIVE MARKET, BY POPULATION TYPE, 2019-2028 (USD MILLION)
TABLE 76 MIDDLE EAST & AFRICA LAXATIVE MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 77 MIDDLE EAST & AFRICA LAXATIVE MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 78 SAUDI ARABIA LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 79 SAUDI ARABIA LAXATIVES MARKET, BY TYPE, 2019-2028 (UNITS)
TABLE 80 SAUDI ARABIA STIMULANT LAXATIVE IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 81 SAUDI ARABIA OSMOTIC LAXATIVE IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 82 SAUDI ARABIA OSMOTIC LAXATIVE WITH ELECTROLYTES IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 83 SAUDI ARABIA OSMOTIC LAXATIVE WITHOUT ELECTROLYTES IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 84 SAUDI ARABIA BULK LAXATIVE IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 85 SAUDI ARABIA LUBRICANT AND EMOLLIENT LAXATIVE IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 86 SAUDI ARABIA LAXATIVE MARKET, BY FLAVORS, 2019-2028 (USD MILLION)
TABLE 87 SAUDI ARABIA WITH FLAVOR IN LAXATIVE MARKET, BY FLAVORS, 2019-2028 (USD MILLION)
TABLE 88 SAUDI ARABIA LAXATIVE MARKET, BY SOURCE, 2019-2028 (USD MILLION)
TABLE 89 SAUDI ARABIA SYNTHETIC IN LAXATIVE MARKET, BY SOURCE, 2019-2028 (USD MILLION)
TABLE 90 SAUDI ARABIA NATURAL IN LAXATIVE MARKET, BY SOURCE, 2019-2028 (USD MILLION)
TABLE 91 SAUDI ARABIA LAXATIVE MARKET, BY INDICATION, 2019-2028 (USD MILLION)
TABLE 92 SAUDI ARABIA LAXATIVE MARKET, BY MODE OF PURCHASE, 2019-2028 (USD MILLION)
TABLE 93 SAUDI ARABIA LAXATIVE MARKET, BY MODE OF PURCHASE, 2019-2028 (UNITS)
TABLE 94 SAUDI ARABIA LAXATIVE MARKET, BY DOSAGE FORM, 2019-2028 (USD MILLION)
TABLE 95 SAUDI ARABIA LAXATIVE MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)
TABLE 96 SAUDI ARABIA LAXATIVE MARKET, BY POPULATION TYPE, 2019-2028 (USD MILLION)
TABLE 97 SAUDI ARABIA LAXATIVE MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 98 SAUDI ARABIA LAXATIVE MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 99 SOUTH AFRICA LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 100 SOUTH AFRICA LAXATIVES MARKET, BY TYPE, 2019-2028 (UNITS)
TABLE 101 SOUTH AFRICA STIMULANT LAXATIVE IN LAXATIVE MARKET, BY TYPE, 2019-2028(USD MILLION)
TABLE 102 SOUTH AFRICA OSMOTIC LAXATIVE IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 103 SOUTH AFRICA OSMOTIC LAXATIVE WITH ELECTROLYTES IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 104 SOUTH AFRICA OSMOTIC LAXATIVE WITHOUT ELECTROLYTES IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 105 SOUTH AFRICA BULK LAXATIVE IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 106 SOUTH AFRICA LUBRICANT AND EMOLLIENT LAXATIVE IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 107 SOUTH AFRICA LAXATIVE MARKET, BY FLAVORS, 2019-2028 (USD MILLION)
TABLE 108 SOUTH AFRICA WITH FLAVOR IN LAXATIVE MARKET, BY FLAVORS, 2019-2028 (USD MILLION)
TABLE 109 SOUTH AFRICA LAXATIVE MARKET, BY SOURCE, 2019-2028 (USD MILLION)
TABLE 110 SOUTH AFRICA SYNTHETIC IN LAXATIVE MARKET, BY SOURCE, 2019-2028 (USD MILLION)
TABLE 111 SOUTH AFRICA NATURAL IN LAXATIVE MARKET, BY SOURCE, 2019-2028 (USD MILLION)
TABLE 112 SOUTH AFRICA LAXATIVE MARKET, BY INDICATION, 2019-2028 (USD MILLION)
TABLE 113 SOUTH AFRICA LAXATIVE MARKET, BY MODE OF PURCHASE, 2019-2028 (USD MILLION)
TABLE 114 SOUTH AFRICA LAXATIVE MARKET, BY MODE OF PURCHASE, 2019-2028 (UNITS)
TABLE 115 SOUTH AFRICA LAXATIVE MARKET, BY DOSAGE FORM, 2019-2028 (USD MILLION)
TABLE 116 SOUTH AFRICA LAXATIVE MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)
TABLE 117 SOUTH AFRICA LAXATIVE MARKET, BY POPULATION TYPE, 2019-2028 (USD MILLION)
TABLE 118 SOUTH AFRICA LAXATIVE MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 119 SOUTH AFRICA LAXATIVE MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 120 U.A.E. LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 121 U.A.E. LAXATIVES MARKET, BY TYPE, 2019-2028 (UNITS)
TABLE 122 U.A.E. STIMULANT LAXATIVE IN LAXATIVE MARKET, BY TYPE, 2019-2028(USD MILLION)
TABLE 123 U.A.E. OSMOTIC LAXATIVE IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 124 U.A.E. OSMOTIC LAXATIVE WITH ELECTROLYTES IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 125 U.A.E. OSMOTIC LAXATIVE WITHOUT ELECTROLYTES IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 126 U.A.E. BULK LAXATIVE IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 127 U.A.E. LUBRICANT AND EMOLLIENT LAXATIVE IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 128 U.A.E. LAXATIVE MARKET, BY FLAVORS, 2019-2028 (USD MILLION)
TABLE 129 U.A.E. WITH FLAVOR IN LAXATIVE MARKET, BY FLAVORS, 2019-2028 (USD MILLION)
TABLE 130 U.A.E. LAXATIVE MARKET, BY SOURCE, 2019-2028 (USD MILLION)
TABLE 131 U.A.E. SYNTHETIC IN LAXATIVE MARKET, BY SOURCE, 2019-2028 (USD MILLION)
TABLE 132 U.A.E. NATURAL IN LAXATIVE MARKET, BY SOURCE, 2019-2028 (USD MILLION)
TABLE 133 U.A.E. LAXATIVE MARKET, BY INDICATION, 2019-2028 (USD MILLION)
TABLE 134 U.A.E. LAXATIVE MARKET, BY MODE OF PURCHASE, 2019-2028 (USD MILLION)
TABLE 135 U.A.E. LAXATIVE MARKET, BY MODE OF PURCHASE, 2019-2028 (UNITS)
TABLE 136 U.A.E. LAXATIVE MARKET, BY DOSAGE FORM, 2019-2028 (USD MILLION)
TABLE 137 U.A.E. LAXATIVE MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)
TABLE 138 U.A.E. LAXATIVE MARKET, BY POPULATION TYPE, 2019-2028 (USD MILLION)
TABLE 139 U.A.E. LAXATIVE MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 140 U.A.E. LAXATIVE MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 141 ISRAEL LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 142 ISRAEL LAXATIVES MARKET, BY TYPE, 2019-2028 (UNITS)
TABLE 143 ISRAEL STIMULANT LAXATIVE IN LAXATIVE MARKET, BY TYPE, 2019-2028(USD MILLION)
TABLE 144 ISRAEL OSMOTIC LAXATIVE IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 145 ISRAEL OSMOTIC LAXATIVE WITH ELECTROLYTES IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 146 ISRAEL OSMOTIC LAXATIVE WITHOUT ELECTROLYTES IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 147 ISRAEL BULK LAXATIVE IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 148 ISRAEL LUBRICANT AND EMOLLIENT LAXATIVE IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 149 ISRAEL LAXATIVE MARKET, BY FLAVORS, 2019-2028 (USD MILLION)
TABLE 150 ISRAEL WITH FLAVOR IN LAXATIVE MARKET, BY FLAVORS, 2019-2028 (USD MILLION)
TABLE 151 ISRAEL LAXATIVE MARKET, BY SOURCE, 2019-2028 (USD MILLION)
TABLE 152 ISRAEL SYNTHETIC IN LAXATIVE MARKET, BY SOURCE, 2019-2028 (USD MILLION)
TABLE 153 ISRAEL NATURAL IN LAXATIVE MARKET, BY SOURCE, 2019-2028 (USD MILLION)
TABLE 154 ISRAEL LAXATIVE MARKET, BY INDICATION, 2019-2028 (USD MILLION)
TABLE 155 ISRAEL LAXATIVE MARKET, BY MODE OF PURCHASE, 2019-2028 (USD MILLION)
TABLE 156 ISRAEL LAXATIVE MARKET, BY MODE OF PURCHASE, 2019-2028 (UNITS)
TABLE 157 ISRAEL LAXATIVE MARKET, BY DOSAGE FORM, 2019-2028 (USD MILLION)
TABLE 158 ISRAEL LAXATIVE MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)
TABLE 159 ISRAEL LAXATIVE MARKET, BY POPULATION TYPE, 2019-2028 (USD MILLION)
TABLE 160 ISRAEL LAXATIVE MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 161 ISRAEL LAXATIVE MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 162 KUWAIT LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 163 KUWAIT LAXATIVES MARKET, BY TYPE, 2019-2028 (UNITS)
TABLE 164 KUWAIT STIMULANT LAXATIVE IN LAXATIVE MARKET, BY TYPE, 2019-2028(USD MILLION)
TABLE 165 KUWAIT OSMOTIC LAXATIVE IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 166 KUWAIT OSMOTIC LAXATIVE WITH ELECTROLYTES IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 167 KUWAIT OSMOTIC LAXATIVE WITHOUT ELECTROLYTES IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 168 KUWAIT BULK LAXATIVE IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 169 KUWAIT LUBRICANT AND EMOLLIENT LAXATIVE IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 170 KUWAIT LAXATIVE MARKET, BY FLAVORS, 2019-2028 (USD MILLION)
TABLE 171 KUWAIT WITH FLAVOR IN LAXATIVE MARKET, BY FLAVORS, 2019-2028 (USD MILLION)
TABLE 172 KUWAIT LAXATIVE MARKET, BY SOURCE, 2019-2028 (USD MILLION)
TABLE 173 KUWAIT SYNTHETIC IN LAXATIVE MARKET, BY SOURCE, 2019-2028 (USD MILLION)
TABLE 174 KUWAIT NATURAL IN LAXATIVE MARKET, BY SOURCE, 2019-2028 (USD MILLION)
TABLE 175 KUWAIT LAXATIVE MARKET, BY INDICATION, 2019-2028 (USD MILLION)
TABLE 176 KUWAIT LAXATIVE MARKET, BY MODE OF PURCHASE, 2019-2028 (USD MILLION)
TABLE 177 KUWAIT LAXATIVE MARKET, BY MODE OF PURCHASE, 2019-2028 (UNITS)
TABLE 178 KUWAIT LAXATIVE MARKET, BY DOSAGE FORM, 2019-2028 (USD MILLION)
TABLE 179 KUWAIT LAXATIVE MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)
TABLE 180 KUWAIT LAXATIVE MARKET, BY POPULATION TYPE, 2019-2028 (USD MILLION)
TABLE 181 KUWAIT LAXATIVE MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 182 KUWAIT LAXATIVE MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 183 EGYPT LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 184 EGYPT LAXATIVES MARKET, BY TYPE, 2019-2028 (UNITS)
TABLE 185 EGYPT STIMULANT LAXATIVE IN LAXATIVE MARKET, BY TYPE, 2019-2028(USD MILLION)
TABLE 186 EGYPT OSMOTIC LAXATIVE IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 187 EGYPT OSMOTIC LAXATIVE WITH ELECTROLYTES IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 188 EGYPT OSMOTIC LAXATIVE WITHOUT ELECTROLYTES IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 189 EGYPT BULK LAXATIVE IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 190 EGYPT LUBRICANT AND EMOLLIENT LAXATIVE IN LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 191 EGYPT LAXATIVE MARKET, BY FLAVORS, 2019-2028 (USD MILLION)
TABLE 192 EGYPT WITH FLAVOR IN LAXATIVE MARKET, BY FLAVORS, 2019-2028 (USD MILLION)
TABLE 193 EGYPT LAXATIVE MARKET, BY SOURCE, 2019-2028 (USD MILLION)
TABLE 194 EGYPT SYNTHETIC IN LAXATIVE MARKET, BY SOURCE, 2019-2028 (USD MILLION)
TABLE 195 EGYPT NATURAL IN LAXATIVE MARKET, BY SOURCE, 2019-2028 (USD MILLION)
TABLE 196 EGYPT LAXATIVE MARKET, BY INDICATION, 2019-2028 (USD MILLION)
TABLE 197 EGYPT LAXATIVE MARKET, BY MODE OF PURCHASE, 2019-2028 (USD MILLION)
TABLE 198 EGYPT LAXATIVE MARKET, BY MODE OF PURCHASE, 2019-2028 (UNITS)
TABLE 199 EGYPT LAXATIVE MARKET, BY DOSAGE FORM, 2019-2028 (USD MILLION)
TABLE 200 EGYPT LAXATIVE MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)
TABLE 201 EGYPT LAXATIVE MARKET, BY POPULATION TYPE, 2019-2028 (USD MILLION)
TABLE 202 EGYPT LAXATIVE MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 203 EGYPT LAXATIVE MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 204 REST OF MIDDLE EAST & AFRICA LAXATIVE MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 205 REST OF MIDDLE EAST & AFRICA LAXATIVE MARKET, BY TYPE, 2019-2028 (UNITS)
Liste des figures
FIGURE 1 MIDDLE EAST AND AFRICA LAXATIVE MARKET: SEGMENTATION
FIGURE 2 MIDDLE EAST AND AFRICA LAXATIVE MARKET: DATA TRIANGULATION
FIGURE 3 MIDDLE EAST AND AFRICA LAXATIVE MARKET: DROC ANALYSIS
FIGURE 4 MIDDLE EAST AND AFRICA LAXATIVE MARKET: MIDDLE EAST AND AFRICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 MIDDLE EAST AND AFRICA LAXATIVE MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 MIDDLE EAST AND AFRICA LAXATIVE MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 MIDDLE EAST AND AFRICA LAXATIVE MARKET: DBMR MARKET POSITION GRID
FIGURE 8 MIDDLE EAST AND AFRICA LAXATIVE MARKET: VENDOR SHARE ANALYSIS
FIGURE 9 MIDDLE EAST AND AFRICA LAXATIVE MARKET: MARKET INDICATION COVERAGE GRID
FIGURE 10 MIDDLE EAST AND AFRICA LAXATIVE MARKET: SEGMENTATION
FIGURE 11 RISING PREVALENCE OF CONSTIPATION, GERIATRIC POPULACE AND INCREASED USE OF OTC LAXATIVE IS EXPECTED TO DRIVE THE MIDDLE EAST AND AFRICA LAXATIVE MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 12 OSMOTIC LAXATIVES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST AND AFRICA LAXATIVE MARKET IN 2021 & 2028
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF MIDDLE EAST AND AFRICA LAXATIVE MARKET
FIGURE 14 PREVALENCE OF CONSTIPATION IN THE AMERICAS, EUROPE AND INDIA
FIGURE 15 PREVALENCE DATA INFOGRAPHICS IN ELDERLY MALES AND FEMALES REPORTED IN THE FOLLOWING COUNTRIES
FIGURE 16 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY TYPE, 2020
FIGURE 17 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY TYPE, 2019-2028 (USD MILLION)
FIGURE 18 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY TYPE, CAGR (2021-2028)
FIGURE 19 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY TYPE, LIFELINE CURVE
FIGURE 20 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY FLAVORS, 2020
FIGURE 21 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY FLAVORS, 2019-2028 (USD MILLION)
FIGURE 22 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY FLAVORS, CAGR (2021-2028)
FIGURE 23 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY FLAVORS, LIFELINE CURVE
FIGURE 24 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY SOURCE, 2020
FIGURE 25 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY SOURCE, 2019-2028 (USD MILLION)
FIGURE 26 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY SOURCE, CAGR (2021-2028)
FIGURE 27 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY SOURCE, LIFELINE CURVE
FIGURE 28 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY INDICATION, 2020
FIGURE 29 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY INDICATION, 2019-2028 (USD MILLION)
FIGURE 30 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY INDICATION, CAGR (2021-2028)
FIGURE 31 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY INDICATION, LIFELINE CURVE
FIGURE 32 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY MODE OF PURCHASE, 2020
FIGURE 33 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY MODE OF PURCHASE, 2019-2028 (USD MILLION)
FIGURE 34 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY MODE OF PURCHASE, CAGR (2021-2028)
FIGURE 35 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY MODE OF PURCHASE, LIFELINE CURVE
FIGURE 36 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY DOSAGE FORM, 2020
FIGURE 37 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY DOSAGE FORM, 2019-2028 (USD MILLION)
FIGURE 38 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY DOSAGE FORM, CAGR (2021-2028)
FIGURE 39 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY DOSAGE FORM, LIFELINE CURVE
FIGURE 40 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY ROUTE OF ADMINISTRATION, 2020
FIGURE 41 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)
FIGURE 42 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY ROUTE OF ADMINISTRATION, CAGR (2021-2028)
FIGURE 43 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY ROUTE OF ADMINISTRATION, LIFELINE CURVE
FIGURE 44 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY POPULATION TYPE, 2020
FIGURE 45 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY POPULATION TYPE, 2019-2028 (USD MILLION)
FIGURE 46 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY POPULATION TYPE, CAGR (2021-2028)
FIGURE 47 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY POPULATION TYPE, LIFELINE CURVE
FIGURE 48 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY SALES CHANNEL, 2020
FIGURE 49 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY SALES CHANNEL, 2019-2028 (USD MILLION)
FIGURE 50 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY SALES CHANNEL, CAGR (2021-2028)
FIGURE 51 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY SALES CHANNEL, LIFELINE CURVE
FIGURE 52 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY DISTRIBUTION CHANNEL, 2020
FIGURE 53 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
FIGURE 54 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY DISTRIBUTION CHANNEL, CAGR (2021-2028)
FIGURE 55 MIDDLE EAST AND AFRICA LAXATIVE MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 56 MIDDLE EAST & AFRICA LAXATIVE MARKET: SNAPSHOT (2020)
FIGURE 57 MIDDLE EAST & AFRICA LAXATIVE MARKET: BY COUNTRY (2020)
FIGURE 58 MIDDLE EAST & AFRICA LAXATIVE MARKET: BY COUNTRY (2021 & 2028)
FIGURE 59 MIDDLE EAST & AFRICA LAXATIVE MARKET: BY COUNTRY (2020 & 2028)
FIGURE 60 MIDDLE EAST & AFRICA LAXATIVE MARKET: BY TYPE (2021-2028)
FIGURE 61 MIDDLE EAST AND AFRICA LAXATIVE MARKET: COMPANY SHARE 2020 (%)
Méthodologie de recherche
La collecte de données et l'analyse de l'année de base sont effectuées à l'aide de modules de collecte de données avec des échantillons de grande taille. L'étape consiste à obtenir des informations sur le marché ou des données connexes via diverses sources et stratégies. Elle comprend l'examen et la planification à l'avance de toutes les données acquises dans le passé. Elle englobe également l'examen des incohérences d'informations observées dans différentes sources d'informations. Les données de marché sont analysées et estimées à l'aide de modèles statistiques et cohérents de marché. De plus, l'analyse des parts de marché et l'analyse des tendances clés sont les principaux facteurs de succès du rapport de marché. Pour en savoir plus, veuillez demander un appel d'analyste ou déposer votre demande.
La méthodologie de recherche clé utilisée par l'équipe de recherche DBMR est la triangulation des données qui implique l'exploration de données, l'analyse de l'impact des variables de données sur le marché et la validation primaire (expert du secteur). Les modèles de données incluent la grille de positionnement des fournisseurs, l'analyse de la chronologie du marché, l'aperçu et le guide du marché, la grille de positionnement des entreprises, l'analyse des brevets, l'analyse des prix, l'analyse des parts de marché des entreprises, les normes de mesure, l'analyse globale par rapport à l'analyse régionale et des parts des fournisseurs. Pour en savoir plus sur la méthodologie de recherche, envoyez une demande pour parler à nos experts du secteur.
Personnalisation disponible
Data Bridge Market Research est un leader de la recherche formative avancée. Nous sommes fiers de fournir à nos clients existants et nouveaux des données et des analyses qui correspondent à leurs objectifs. Le rapport peut être personnalisé pour inclure une analyse des tendances des prix des marques cibles, une compréhension du marché pour d'autres pays (demandez la liste des pays), des données sur les résultats des essais cliniques, une revue de la littérature, une analyse du marché des produits remis à neuf et de la base de produits. L'analyse du marché des concurrents cibles peut être analysée à partir d'une analyse basée sur la technologie jusqu'à des stratégies de portefeuille de marché. Nous pouvons ajouter autant de concurrents que vous le souhaitez, dans le format et le style de données que vous recherchez. Notre équipe d'analystes peut également vous fournir des données sous forme de fichiers Excel bruts, de tableaux croisés dynamiques (Fact book) ou peut vous aider à créer des présentations à partir des ensembles de données disponibles dans le rapport.
